|
|
|
Corporate Profile: Anchor Therapeutics
| Summary: |
Anchor Therapeutics is focused on development of pepducins for targeting G protein coupled receptors (GPCRs) on the inside surface of the cell membrane.
|
| Address (HQ): |
One Kendall Square
Building 200
Suite 2203
Cambridge, MA 02139
|
| Phone #'s (HQ): |
| Main |
(617) 715-1999 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(617) 715-7906 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
